BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

181 hedge funds and large institutions have $1.44B invested in BridgeBio Pharma in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 72 increasing their positions, 48 reducing their positions, and 14 closing their positions.

Holders
181
Holders Change
+17
Holders Change %
+10.37%
% of All Funds
3.13%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
31
Increased
72
Reduced
48
Closed
14
Calls
$4.5M
Puts
$3.19M
Net Calls
+$1.31M
Net Calls Change
-$4.18M

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$11.9M
2
GPP
2
Great Point Partners
Connecticut
$10.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$18M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$13.6M
5
Voloridge Investment Management
5
Voloridge Investment Management
Florida
$8.16M

Top Sellers

1
State Street
1
State Street
Massachusetts
$79M
2
AC
2
Aristeia Capital
Connecticut
$1.49M
3
Morgan Stanley
3
Morgan Stanley
New York
$10.2M
4
CS
4
Candriam SCA
Luxembourg
$952K
5
Charles Schwab
5
Charles Schwab
California
$7.67M
Name Market Value Shares Shares
Change 		Shares
Change %
SIC
201
SJS Investment Consulting
Ohio
$0 2 +2 New
SC
202
Schubert & Co
Texas
$0 32 +16 +100%
JWA
203
JFS Wealth Advisors
Pennsylvania
$0 30 +16 +114%
CAL
204
Capital Advisors Ltd
Ohio
$0 18 +18 New
5 6 7 8
9